21 February 2012
Taking place at Nabarro LLP in London on April 19, is an independent, one-day event bringing together low-carbon industry leaders, investors and stakeholders to focus on identifying, building and growing businesses in the sector.
09 March 2011
The Traded Policies Fund invests in Traded Life Policies (TLPs), an asset class which has delivered smooth, predictable investment returns independent of interest rates, equities and commodities.
18 January 2011
One option if you are a budding entrepreneur looking to start your own business is to buy a franchise.
18 October 2010
Whether you’re putting money aside for a rainy day or a world cruise, Melanie Wright’s tips will help you make the most of your savings.
21 June 2010
With the debate surrounding funding long term care in the run up to the last general election, few areas have been as topical or well publicized.
21 June 2010
For investment professionals only. Not approved for use with customers.
19 April 2010
The primary objective for the UBS US Large Cap Growth Team, based in New York, is to discover growth opportunities that have been underestimated or overlooked by the wider market. The US has provided fertile ground to such investors over the past 18 months, leading to impressive results for the UBS US Growth Fund.
26 March 2010
You save without paying UK tax on the interest you earn, providing all ISA conditions are met – that’s the simple appeal of ISA accounts.
12 February 2010
Launching a new business is an exciting and rewarding experience, but nobody expects you to know everything about it right at the start. True, you're expected to know your own products and services, and the market in which you're operating. But there's much more to it than that.
07 December 2009
The next financial crisis will be sparked by the rise of giant daily dealing bond funds and ETFs, GLG’s top performing fixed income manager Jon Mawby has warned.
Matt Kamm, managing director of Artisan Partners, explains why, following their upswing, biotech stocks are still early in a pharmaceutical renaissance which should capture investor attention.
With monetary policy weakening the yen and a consumption tax rise at home, Japan's multinationals are the key to solving the country's problems - and the best bet for investors, says Neptune's Chris Taylor.
The Big Debate
The Big Debate is an online audio and video conferencing club with an audience comprising the UK's leading discretionary asset managers, top IFAs, and other investment professionals.
IW Fund Centre
Register here to get full access to all Investment Week's news and comment articles from our archive.
Updating your subscription status